International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 2, Issue 6 | Research Article | Open Access

Treatment of Chronic Fatigue Syndrome (CFS) in Post-SARS-CoV-2 Infection through combined outpatient Neuromodulation Therapy with Repetitive Transcranial Magnetic Stimulation (rTMS) and Ketamine IV Therapy - A Case Series

Chiara Rolle* , Mario Scheib, Anja Frank, Isabella Russ^*

Psychologic Psychotherapist, Neuropsychology, Psychologist, Munich, Germany

^*Correspondence to: Chiara Rolle* , Mario Scheib, Anja Frank, Isabella Russ 

Abstract

The most reported symptom of post-COVID syndrome is pronounced fatigue.In this case series, we present the treatment of four patients suffering from Post-COVID syndrome after more than 3 months since infection, presented diagnostically within the framework of chronic fatigue syndrome (CFS). They were treated with a combination of Low-frequency (1 Hz) repetitive transcranial magnetic stimulation(rTMS) and ketamine intravenous (IV) infusion therapy for a period of 2 to 3 weeks. Three patients experienced significant improvement. Given the promising results further research is indicated.

Keywords:

Post-COVID Syndrome; SARS-CoV-2; Ketamine; rTMS; Chronic Fatigue Syndrome; Neuroplasticit

Citation:

Chiara Rolle, Mario Scheib, Anja Frank, Isabella Russ. Treatment of Chronic Fatigue Syndrome (CFS) in Post-SARS-CoV-2 Infection through combined outpatient Neuromodulation Therapy with Repetitive Transcranial Magnetic Stimulation (rTMS) and Ketamine IV Therapy - A Case Series.Int Clinc Med Case Rep Jour. 2023;2(6):1-7.